SeenewsSeenews
Search
Seenews
AlertsSeenewsSeenews
Searchclose
TOPICS
arrow
COUNTRIES
arrow
INDUSTRY
arrow
Economy
arrow
Browse Economy
Mix and match your focus countries with our advanced search
Investments
arrow
Browse Investments
Mix and match your focus countries with our advanced search
Deals
arrow
Browse Deals
Mix and match your focus countries with our advanced search
SEE TOP 100
arrow
Browse SEE TOP 100
Latest in SEE TOP 100
Tech
arrow
Browse Tech
Mix and match your focus countries with our advanced search
Green
arrow
Browse Green
Mix and match your focus countries with our advanced search
0/5
You have 5 free articles left this month
You have 0/5 free articles
Sign up to get 5 more free articles this month
SIGN UP
arrow
LOGIN
arrow

Romanian Drug Market Grows 17.8% in Year Ended June 30 - Researcher

Sep 14, 2009, 5:43:00 PMArticle by Georgi Georgiev
share
BUCHAREST (Romania), September 14 (SeeNews) – Romania's pharmaceuticals market rose by 17.8% to 7.6 billion lei ($2.6 billion/1.8 billion euro) in the twelve-month period through June 30, 2009, a survey by market research company Cegedim Romania showed on Monday.

Romanian Drug Market Grows 17.8% in Year Ended June 30 - Researcher

The driving force behind the market growth were retail sales, which accounted for 86.8% of total sales over the period, the survey showed.

The drug market expanded by 4.7% in the three-month period through June this year to 1.89 billion lei.

In the twelve months ended June 30, 2009, Hoffmann La Roche led the market in terms of sales value with an 8.1% share, followed by France’s Sanofi-Aventis with 6.9% and Britain’s GSK with 6.7%. Swiss Novartis ranked fourth with a market share of 6.2%.

Local drug makers Terapia Ranbaxy, Zentiva S.A. and Antibiotice had market shares of 4.4%, 3.7% and 2.7%, respectively.

Cegedim said earlier it expected the local drug market to grow by around 10% this year from 7.2 billion lei in 2008.

(1 euro = 4.2729 Romanian lei)

Your complete guide to the emerging economies of Southeast Europe. From latest news to bespoke research – the big picture at the tip of your fingers.